文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.

作者信息

Li Lijuan, Wu Jian, Sima Xiutian, Bai Peng, Deng Wei, Deng Xueke, Zhang Lin, Gao Linbo

机构信息

Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.

出版信息

Tumour Biol. 2013 Jun;34(3):1919-23. doi: 10.1007/s13277-013-0736-9. Epub 2013 Mar 17.


DOI:10.1007/s13277-013-0736-9
PMID:23504554
Abstract

Growing evidence indicates that tumor suppressor gene TP-53 and non-coding RNA miR-34b/c independently and/or jointly play crucial roles in carcinogenesis. We hypothesized that the polymorphisms of rs4938723 in the promoter region of pri-miR-34b/c and TP-53 Arg72-Pro may be related to the risk of nasopharyngeal carcinoma (NPC). We performed a case-control study between 217 patients with NPC and 360 healthy controls in a Chinese population using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. A significantly increased risk of NPC was observed in the miR-34b/c rs4938723 CT/CC genotypes compared with the TT genotype (adjusted OR=1.44, 95 % CI 1.02-2.03, p=0.04), and also the C allele (adjusted OR=1.33, 95 % CI 1.04-1.70, p=0.03). The gene-gene interaction of miR-34b/c rs4938723 and TP-53 Arg72-Pro showed that the combined genotypes of rs4938723CT/CC and TP-53CG/CC increased the risk of NPC (rs4938723CT/CC + TP-53CG/CC vs. rs4938723 TT+TP-53 CG/CC: OR=1.58, 95 % CI 1.04-2.42, p=0.03). These findings suggest that miR-34b/c rs4938723 and TP-53 Arg72Pro polymorphisms may singly or collaboratively contribute to the risk of NPC.

摘要

相似文献

[1]
Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.

Tumour Biol. 2013-6

[2]
Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.

Medicine (Baltimore). 2015-9

[3]
Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.

Tumour Biol. 2016-5

[4]
Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.

Tumour Biol. 2014-12

[5]
Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.

Genet Test Mol Biomarkers. 2015-4

[6]
Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm.

Clin Dev Immunol. 2012

[7]
Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.

Gene. 2013-4-28

[8]
Interactions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis.

Genet Test Mol Biomarkers. 2016-7

[9]
Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.

Arch Med Res. 2019-6-12

[10]
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.

Int J Cancer. 2010-3-22

引用本文的文献

[1]
20()-Protopanaxatriol promotes the binding of P53 and DNA to regulate the antitumor network multiomic analysis.

Acta Pharm Sin B. 2020-6

[2]
rs4938723 T>C Decreases Neuroblastoma Risk: A Replication Study in the Hunan Children.

Dis Markers. 2019-9-10

[3]
Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers.

Transl Oncol. 2019-10

[4]
Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma.

Front Oncol. 2018-9-26

[5]
Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.

Med Sci Monit. 2018-10-4

[6]
Association between Pri-miR-34b/c rs4938723 polymorphism and bladder cancer risk.

J Biomed Res. 2018-9-6

[7]
Genetic polymorphisms of non-coding RNAs associated with increased head and neck cancer susceptibility: a systematic review and meta-analysis.

Oncotarget. 2017-8-9

[8]
Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology.

Oncotarget. 2017-4-13

[9]
An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.

Oncotarget. 2017-4-25

[10]
pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.

Int J Mol Epidemiol Genet. 2017-2-15

本文引用的文献

[1]
A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.

Biol Chem. 2013-3

[2]
Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.

Genet Mol Res. 2012-9-25

[3]
Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm.

Clin Dev Immunol. 2012

[4]
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

BMC Med Genomics. 2012-1-19

[5]
p53 and microRNA-34 are suppressors of canonical Wnt signaling.

Sci Signal. 2011-11-1

[6]
Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.

World J Gastroenterol. 2011-9-14

[7]
microRNA expression profiling of nasopharyngeal carcinoma.

Oncol Rep. 2011-3-3

[8]
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.

Nat Genet. 2010-5-30

[9]
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.

Int J Cancer. 2010-3-22

[10]
Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.

Cancer Genet Cytogenet. 2010-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索